IMMTAX Trademark

Trademark Overview


On Tuesday, May 11, 2021, a trademark application was filed for IMMTAX with the United States Patent and Trademark Office. The USPTO has given the IMMTAX trademark a serial number of 90702511. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2024. This trademark is owned by Immunocore Limited. The IMMTAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, bispecific molecules for the treatment of cancer, tumorous diseases, infectious diseases and autoimmune diseases; biological preparations for the treatment of cancer, namely, biological preparations containing T cell receptors which target cancerous cells; biological preparations for the treatment of viral infections, namely, biological preparations containing T cell receptors which target virally infected cells; biological preparations for the treatment of bacterial infections, namely, biological preparations containing T cell receptors which target bacterially infected cells; biological preparations for the treatment of autoimmune diseases, namely, biological preparations containing T cell receptors fused to immune suppressive effectors to generate organ-specific immune suppression; immunotherapeutic drugs, namely, bispecific molecules for the targeted activation of or suppression of immune responses
immtax

General Information


Serial Number90702511
Word MarkIMMTAX
Filing DateTuesday, May 11, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, bispecific molecules for the treatment of cancer, tumorous diseases, infectious diseases and autoimmune diseases; biological preparations for the treatment of cancer, namely, biological preparations containing T cell receptors which target cancerous cells; biological preparations for the treatment of viral infections, namely, biological preparations containing T cell receptors which target virally infected cells; biological preparations for the treatment of bacterial infections, namely, biological preparations containing T cell receptors which target bacterially infected cells; biological preparations for the treatment of autoimmune diseases, namely, biological preparations containing T cell receptors fused to immune suppressive effectors to generate organ-specific immune suppression; immunotherapeutic drugs, namely, bispecific molecules for the targeted activation of or suppression of immune responses

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunocore Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Trademark Events


Event DateEvent Description
Friday, May 14, 2021NEW APPLICATION ENTERED
Wednesday, August 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 4, 2021ASSIGNED TO EXAMINER
Monday, October 4, 2021NON-FINAL ACTION WRITTEN
Monday, October 4, 2021NON-FINAL ACTION E-MAILED
Monday, October 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 7, 2022FINAL REFUSAL E-MAILED
Thursday, April 7, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 7, 2022FINAL REFUSAL WRITTEN
Thursday, October 6, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, November 25, 2022ASSIGNED TO LIE
Saturday, November 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 25, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, July 13, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, August 29, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, November 20, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY